Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Current Issue
Editorial
Images/Videos in Hematology
Letter to the Editor
Meta-Analysis
Original Article
Original Research
Residents’ Corner
Review Article
Systematic Review
Systematic Reviews
What the Expert Says
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Current Issue
Editorial
Images/Videos in Hematology
Letter to the Editor
Meta-Analysis
Original Article
Original Research
Residents’ Corner
Review Article
Systematic Review
Systematic Reviews
What the Expert Says
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Case Report
Case Series
Current Issue
Editorial
Images/Videos in Hematology
Letter to the Editor
Meta-Analysis
Original Article
Original Research
Residents’ Corner
Review Article
Systematic Review
Systematic Reviews
What the Expert Says
View/Download PDF

Translate this page into:

Case Report
ARTICLE IN PRESS
doi:
10.25259/JHAS_15_2025

A rare aberrant alpha-2 band in an elderly anemic patient

Department of Biochemistry, AIG Hospitals, Hyderabad, Telangana, India.
Department of Haemato-oncology, AIG Hospitals, Hyderabad, Telangana, India.

*Corresponding author: Vidyavathi Devi GajapathiRaju, Department of Biochemistry, AIG Hospitals, Hyderabad, Telangana, India. vidyavathidevi.1@gmail.com

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: GajapathiRaju V, Gujjarlapudi D, Ajinath WB, Mahavadi S. A rare aberrant alpha-2 band in an elderly anemic patient. J Hematol Allied Sci. doi: 10.25259/JHAS_15_2025

Abstract

Serum protein electrophoresis (SPE) is ordered to diagnose cases of multiple myelomas by detecting monoclonal bands of protein. In this case, an elderly female anemic patient was found to have a monoclonal band in the alpha-2 region. As this is an uncommon presentation and there was no derangement in the kappa-lambda ratio and no accompanying band on Serum immunofixation electrophoresis (IFE) a further look was taken into the history and other investigations that were ordered for this patient to determine the cause. A repeat sample was collected 3 days later which revealed attenuation of this band (Institutional ethics committee approval number – Post BH&R 67/02.2025-07).

Keywords

Alpha globulins
Capillary zone electrophoresis
Monoclonal gammopathy
Pre-analytic phase
Specimen collection

INTRODUCTION

Serum protein electrophoresis (SPE) is ordered for detecting and quantifying a monoclonal protein when a patient is suspected of having a monoclonal gammopathy. Monoclonal gammopathy occurs when there is a selective propagation of a single clone of plasma cells producing a single clone of immunoglobulins which appears as a “M spike” on protein electrophoresis. It ranges from benign monoclonal gammopathy of undetermined significance to malignant multiple myelomas. It affects mainly older people and males are more commonly affected than females.[1]

Our case elaborated below showed an aberrant (extra) peak in the alpha-2 region. As monoclonal peaks are more common in the gamma region followed by the beta region,[2] this case merited follow-up with extensive history and correlation with other investigations to determine its cause.

Our study was approved by the institute’s ethics committee. Approval number: post BH&R 67/02.2025-07.

CASE REPORT

A 72-year-old female patient presented to our outpatient department with a history of recurrent anemia for which she received repeated transfusion over the past 5 years. She also had pain abdomen with recurrent aphthous ulcers of the mouth and a history of frequent use of nonsteroidal anti-inflammatory drugs (diclofenac/aceclofenac) for 20 years which she discontinued 5 years ago. Due to a sharp drop in hemoglobin (Hb) and considering her age, the hematooncologist referred her for SPE to rule out multiple myelomas. Routine tests revealed a slightly elevated creatinine and microcytic hypochromic anemia with a Hb of 7.6 g/dL [Table 1]. Upper gastrointestinal endoscopy revealed hyperemia with small superficial ulcers in the duodenum. Triphasic contrast-enhanced computed tomography (CECT) of the liver suggested the possibility of cryptogenic multifocal ulcerous stenosing enteritis.

Table 1: Results of Laboratory Investigations
Test Result Biological reference range
Renal function tests
  Blood urea (mg/dL) 31 17 - 49
  Serum creatinine (mg/dL) 1.25 0.51 - 0.95
  Sodium (mEq/L) 136 136 - 145
  Potassium (mEq/L) 5.0 3.5 - 5.1
  Chloride (mEq/L) 106 98 - 107
Liver function tests
  Total bilirubin (mg/dL) 0.5 0.3 - 1.2
  Direct bilirubin (mg/dL) 0.1 0-0.2
  Indirect bilirubin 0.4
  S.G.O.T (AST) (U/L) 31 <35
  S.G.P.T (ALT) (U/L) 16 <34
  ALP (U/L) 99 53 - 141
  Total proteins (g/dL) 6.8 6.2 - 8.1
  Albumin (Serum) (g/dL) 3.4 3.2 - 4.6
  Globulin (g/dL) 3.4 2.3 - 3.5
Iron studies
  Iron (ug/dL) 11 60 - 180
  TIBC (ng/mL) 349 250 - 450
  Ferritin (ng/mL) 12.2 10.0 - 204.0
  Vitamin B12 (pg/mL) 242 197 – 771
  Folic acid (ng/mL) 10.4 4.6 - 18.7
  Vitamin D (ng/mL) 43.1 Deficiency: < 20
Insufficiency: 20 - 30 Sufficiency: 30 - 100 Toxicity: > 100
Serum free light chains
  Kappa, free light chain (mg/L) 56.81 3.30 - 19.40
  Lambda, free light chain (mg/L) 33.81 5.71 - 26.30
  Kappa/lambda, ratio 1.68 0.26-1.65
Hemogram
  Hemoglobin (g/dL) 7.6 12.0 - 15.0
  RBC (cells/mm3) 2.72 3.8-4.8
  PCV (%) 23.4 36-46
  MCV (fL) 85.9 83 - 101
  MCH (pg) 27.9 27 - 32
  MCHC (g/dL) 32.5 31.5-34.5
  RDW (%) 15.3 11.6 - 14
  Total WBC (cells/mm3) 5820 4000 - 10000
Differential count
  Neutrophils (%) 56.5 40-80
  Lymphocytes (%) 28.3 20 - 40
  Eosinophils (%) 3.7 1.0 - 6.0
  Monocytes (%) 9.8 0-7
  Basophils (%) 1.7 0-2
Absolute leucocyte count
  Absolute neutrophil count (cells/mm3) 3288 2000 - 7000
  Absolute lymphocyte count (cells/mm3) 1647 1000 - 3000
  Absolute eosinophil count (cells/mm3) 215 20 - 500
  Absolute monocyte count (cells/mm3) 570 200 - 1000
  Absolute basophil count (cells/mm3) 99 0 - 100
  Neutrophil lymphocyte ratio 2.0
  Platelet count (103/mm3) 622 150-410
  MPV (fL) 6.9 7.4-10.4
Peripheral smear
  RBC morphology Normocytic normochromic with few microcytes
  WBC morphology Within normal limits
  Platelets Thrombocytosis
  Abnormal cells Nil
  Hemoparasites Nil
  Erythrocyte sedimentation rate (ESR)(mm/hr) 41 0-35

SPE was run by capillary zone electrophoresis (Minicap Flex-Piercing analyser, Sebia, Lisses, France). It showed two distinct peaks in the alpha-2 region and acute inflammation [Figure 1]. Kappa lambda ratio (Nephelometry, the Atellica Neph630, Siemens, Forchheim, Germany) was within normal limits. Immunofixation electrophoresis (IFE) was done in serum (3351– QuickGel IFE Kit, Helena, UK). It showed normal polyclonal distribution of immunoglobulins – no monoclonal bands.

The initial serum protein electrophoresis result for the 72-year-old female patient showing the distribution of various protein fractions. An aberrant peak (a second peak), indicated by the red arrow, is visible in the alpha-2 globulin region.
Figure 1:
The initial serum protein electrophoresis result for the 72-year-old female patient showing the distribution of various protein fractions. An aberrant peak (a second peak), indicated by the red arrow, is visible in the alpha-2 globulin region.

Due to the presence of the aberrant peak in a patient with normal kappa-lambda ratio and no monoclonal bands detected on IFE, we took a thorough look into the patient’s history, reports, and investigations.

We determined that a CECT was ordered for this patient for which the patient was administered 70 mL non-ionic iodinated contrast (iohexol) intravenously. The blood sample for SPE was collected following CECT.

Thus, a repeat serum sample was collected from the patient 3 days later and SPE rerun on the fresh sample. The repeat SPE showed attenuation of the aberrant peak in the alpha-2 region, protein loss, and acute inflammation [Figure 2]. The presence of an extra peak in the first SPE and its elimination in the second SPE is consistent with the administration and excretion of an exogenous substance (radio-opaque dye) which is consistent with the history of the patient.

The serum protein electrophoresis results for the same 72-year-old female patient performed after 3 days. The red arrow indicates the attenuation of the aberrant peak.
Figure 2:
The serum protein electrophoresis results for the same 72-year-old female patient performed after 3 days. The red arrow indicates the attenuation of the aberrant peak.

DISCUSSION

The diagnostic features of multiple myelomas include a monoclonal band on protein electrophoresis, clonal plasma cells of >10% on bone marrow biopsy, and one or more features of end-organ damage, the so called CRAB symptoms, which are hyperCalcemia of >11g/dL, Renal failure indicated by serum creatinine of more than 2g/dL or glomerular filtration rate (GFR) of less than 40 mL/min, Anemia of < 10 g/dL or a recent drop in hemoglobin of >2g/dL, and lytic Bone lesions on x-ray, CT or MRI.[1]

This patient is a 72-year-old female with an Hb of 7.6 g/dL with an aberrant band (M band) in the alpha-2 region. When such a sharp M band is visible on protein electrophoresis in an elderly symptomatic patient, the diagnosis of multiple myelomas has to be considered. Monoclonal bands are most common in the gamma region followed by the beta-2 and beta-1 regions.[2] Monoclonal bands in the alpha-2 region are rare and other causes of the appearance of such bands – variant phenotypes of haptoglobin, improper haptoglobin-Hb complex that forms due to hemolysis, or radiopaque dyes[3-5] – have to be considered. In SPE, as with most investigations, several pre-analytical errors might occur due to the collection of improper sample or contamination during sample collection. There was no hemolysis in the sample. Serum kappa lambda ratio and serum IFE were within normal limits suggesting that a monoclonal protein is not causing the band. Since this patient’s blood was collected following the administration of non-ionic iodinated contrast (iohexol) and not before as per protocol, the iodinated contrast was considered the most probable cause.

A repeat sample was collected after 3 days which showed attenuation of the peak – the disappearance of this band suggests the presence of an exogenous administered substance which was then eliminated (excreted) by the patient which based on the history of the patient indicate that it was caused by the non-ionic iodinated contrast (iohexol) used for CECT. Organic iodine molecules (e.g., iohexol, iodixanol, and ioversol) have been shown to interfere in several biochemical assays including cardiac troponin I and SPE.[6] Thus, drawing of a blood sample should be done before administration of the contrast dye.

Similar bands in the alpha region due to contrast dye have also been observed by other researchers.[5,7,8] Duggal et al. found five cases of monoclonal bands in the alpha region due to lambda isotype on immunofixation.[9] This suggests that IFE of immunotyping electrophoresis should be done in all cases of monoclonal bands in the alpha-2 region.

Being alert and aware that not all bands on protein electrophoresis indicate a monoclonal protein, especially when not accompanied by a band on IFE enabled us to avoid unnecessary further investigations and interventions.

CONCLUSION

The knowledge of different contaminants that can cause aberrant bands in protein electrophoresis helps us identify the actual cause and not misdiagnose the patient as one of multiple myelomas, avoiding unnecessary investigations and interventions.

Ethical approval:

The research/study was approved by the Institutional Review Board at IEC-AIG, number Post BH&R 67/02.2025-07, dated 25th February 2025.

Declaration of patient consent:

The authors certify that they have obtained all appropriate patient consent.

Conflicts of interest:

There are no conflicts of interest.

Use of artificial intelligence (AI)-assisted technology for manuscript preparation:

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

Financial support and sponsorship: Nil.

References

  1. , , , , , , et al. International myeloma working group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol. 2014;15:e538-48.
    [CrossRef] [PubMed] [Google Scholar]
  2. . The role of serum protein electrophoresis in the detection of multiple myeloma: An experience of a corporate hospital. J Clin Diagn Res. 2012;6:1458-61.
    [CrossRef] [PubMed] [Google Scholar]
  3. , , , , , . A new method for fast haptoglobin phenotyping and hemoglobin binding capacity calculation based on capillary zone electrophoresis. Clin Chem Lab Med. 2000;38:715-20.
    [CrossRef] [PubMed] [Google Scholar]
  4. , , , . Factors influencing the electrophoretic analysis of human serum. J Biol Chem. 1949;180:1147-58.
    [CrossRef] [PubMed] [Google Scholar]
  5. , , . Large abnormal peak on capillary zone electrophoresis due to contrast agent. Ann Clin Biochem. 2018;55:608-11.
    [CrossRef] [PubMed] [Google Scholar]
  6. , , . Interference of medical contrast media on laboratory testing. Biochem Med (Zagreb). 2014;24:80-8.
    [CrossRef] [PubMed] [Google Scholar]
  7. , , . Interference of radio-opaque agents in clinical capillary zone electrophoresis. Clin Chem. 1999;45:129-31.
    [CrossRef] [PubMed] [Google Scholar]
  8. , , , , . Interference of iodinated contrast media in serum capillary zone electrophoresis. Clin Chem. 2000;46:736-7.
    [CrossRef] [PubMed] [Google Scholar]
  9. , , , , . Occurrence of monoclonal band in alpha region on serum electrophoresis in multiple myeloma: A diagnostic conundrum. Indian J Hematol Blood Transfus. 2025;41:155-60.
    [CrossRef] [PubMed] [Google Scholar]
Show Sections